Xanamem is an investigational product and is not approved for use outside of a clinical trial by the FDA or by any global regulatory authority. Xanamem ® is a trademark of Actinogen Medical.
An analysis of an unusual enzyme could result in a new generation of antimicrobial medicines to counter antibiotic resistance. Key details in the enzyme-driven biosynthesis of a natural molecule with ...
The immune system must maintain a delicate balance to defend against harmful threats while avoiding excessive inflammation.
Transporters and drug-metabolizing enzymes are critical determinants of drug disposition and response. Beyond their classical roles in pharmacokinetics, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results